HomeCompareAAFTX vs JNJ

AAFTX vs JNJ: Dividend Comparison 2026

AAFTX yields 6.22% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AAFTX wins by $10.1K in total portfolio value
10 years
AAFTX
AAFTX
● Live price
6.22%
Share price
$20.08
Annual div
$1.25
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.2K
Annual income
$924.26
Full AAFTX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — AAFTX vs JNJ

📍 AAFTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAAFTXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AAFTX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AAFTX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AAFTX
Annual income on $10K today (after 15% tax)
$528.67/yr
After 10yr DRIP, annual income (after tax)
$785.62/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, AAFTX beats the other by $82.01/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AAFTX + JNJ for your $10,000?

AAFTX: 50%JNJ: 50%
100% JNJ50/50100% AAFTX
Portfolio after 10yr
$25.1K
Annual income
$876.02/yr
Blended yield
3.49%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

AAFTX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AAFTX buys
0
JNJ buys
0
No recent congressional trades found for AAFTX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAAFTXJNJ
Forward yield6.22%3.36%
Annual dividend / share$1.25$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$30.2K$20.0K
Annual income after 10y$924.26$827.78
Total dividends collected$7.8K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AAFTX vs JNJ ($10,000, DRIP)

YearAAFTX PortfolioAAFTX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,322$621.96$10,676$355.77+$646.00AAFTX
2$12,773$658.12$11,407$389.39+$1.4KAAFTX
3$14,361$693.87$12,198$426.53+$2.2KAAFTX
4$16,095$729.10$13,056$467.62+$3.0KAAFTX
5$17,985$763.69$13,987$513.12+$4.0KAAFTX
6$20,042$797.56$14,998$563.56+$5.0KAAFTX
7$22,275$830.61$16,098$619.52+$6.2KAAFTX
8$24,697$862.78$17,295$681.69+$7.4KAAFTX
9$27,320$894.01$18,599$750.82+$8.7KAAFTX
10$30,157$924.26$20,022$827.78+$10.1KAAFTX

AAFTX vs JNJ: Complete Analysis 2026

AAFTXStock

The fund normally invests a greater portion of its assets in fixed income, equity-income and balanced funds as it approaches and passes its target date. The advisor attempts to achieve its investment objectives by investing in a mix of American Funds in different combinations and weightings. The underlying American Funds represent a variety of fund categories, including growth funds, growth-and-income funds, equity-income funds, balanced funds and fixed income funds. The fund categories represent differing investment objectives and strategies.

Full AAFTX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this AAFTX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AAFTX vs SCHDAAFTX vs JEPIAAFTX vs OAAFTX vs KOAAFTX vs MAINAAFTX vs ABBVAAFTX vs MRKAAFTX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.